Hapvida Participações e Investimentos S.A. (BVMF:HAPV3)

Brazil flag Brazil · Delayed Price · Currency is BRL
10.31
-0.27 (-2.55%)
Jun 19, 2026, 5:05 PM GMT-3
Market Cap5.03B -76.4%
Revenue (ttm)31.85B -10.0%
Net Income-428.85M
EPS-0.86
Shares Out 475.06M
PE Ration/a
Forward PE8.28
Dividendn/a
Ex-Dividend Daten/a
Volume5,614,100
Open10.65
Previous Close10.58
Day's Range10.31 - 10.70
52-Week Range7.00 - 42.66
Beta0.29
AnalystsHold
Price Target13.96 (+35.4%)
Earnings DateAug 12, 2026

About BVMF:HAPV3

Hapvida Participações e Investimentos S.A., together with its subsidiaries, operates in the healthcare sector in Brazil. It sells health insurance plans through its own clinical, outpatient, and hospital networks, as well as dental plans through an accredited network. Hapvida Participações e Investimentos S.A. was founded in 1979 and is headquartered in Fortaleza, Brazil. [Read more]

Sector Financials
Founded 1979
Employees 68,000
Stock Exchange Brazil Stock Exchange
Ticker Symbol HAPV3
Full Company Profile

Financial Performance

In 2025, BVMF:HAPV3's revenue was 31.58 billion, an increase of 9.21% compared to the previous year's 28.91 billion. Losses were -141.75 million, -78.17% less than in 2024.

Financial Statements

Analyst Summary

According to 13 analysts, the average rating for HAPV3 stock is "Hold." The 12-month stock price target is R$13.96, which is an increase of 35.40% from the latest price.

Price Target
R$13.96
(35.40% upside)
Analyst Consensus: Hold
Stock Forecasts

News

Hapvida Participacoes upgraded to Buy from Hold at Jefferies

Jefferies upgraded Hapvida Participacoes (HAPVY) to Buy from Hold with a price target of R$19, down from R$31.50. 2025 was “a perfect storm” as Hapvida faced a convergence of commercial,…

5 weeks ago - TheFly

Hapvida Participações e Investimentos Earnings Call Transcript: Q1 2026

Revenue reached BRL 7.9 billion with improved average ticket and strong cash generation, despite a net member loss and ongoing cost pressures. Operational turnaround and asset optimization are underway, with a focus on margin protection and deleveraging.

5 weeks ago - Transcripts

Hapvida Participações e Investimentos Earnings release: Q1 2026

Hapvida Participações e Investimentos released its Q1 2026 earnings on May 12, 2026, summarizing the period's financial results.

5 weeks ago - Filings

Hapvida Participações e Investimentos Slides: Q1 2026

Hapvida Participações e Investimentos has posted slides in relation to its Q1 2026 quarterly earnings report, which was published on May 12, 2026.

5 weeks ago - Filings

Hapvida Participacoes downgraded to Neutral from Outperform at Bradesco BBI

Bradesco BBI downgraded Hapvida Participacoes (HAPVY) to Neutral from Outperform with a R$14 price target

7 weeks ago - TheFly

Hapvida Participações e Investimentos Slides: Investor presentation

Hapvida Participações e Investimentos has posted slides in relation to its latest quarterly earnings report, which was published on April 14, 2026.

2 months ago - Filings

Hapvida Participações e Investimentos Earnings Call Transcript: Q4 2025

Q4 2025 results missed expectations due to high MLR and weak member growth, especially in competitive regions. Transformation initiatives, stricter capital discipline, and a CEO transition are underway, with 2026 focused on margin recovery, operational efficiency, and selective growth.

3 months ago - Transcripts

Hapvida Participações e Investimentos Earnings release: Q4 2025

Hapvida Participações e Investimentos released its Q4 2025 earnings on March 19, 2026, summarizing the period's financial results.

3 months ago - Filings

Hapvida Participações e Investimentos Slides: Q4 2025

Hapvida Participações e Investimentos has posted slides in relation to its Q4 2025 quarterly earnings report, which was published on March 19, 2026.

3 months ago - Filings

Brazil's Hapvida shares plunge nearly 40% after disappointing Q3 results

Brazilian health provider Hapvida (HAPV3) declared a net profit of R$338 million on Wednesday night, but the third quarter of 2025 proved to be quite disappointing. According to local media outlet Inf...

7 months ago - Invezz

Hapvida Participações e Investimentos Earnings Call Transcript: Q3 2025

Q3 2025 saw margin pressure from higher utilization and new unit costs, but customer satisfaction and operational metrics improved. Membership growth was below expectations, with robust corporate gains offset by tough competition in other segments. Margin recovery and cost dilution are expected as new units mature and pricing adjustments take effect.

7 months ago - Transcripts

Hapvida Participações e Investimentos Earnings release: Q3 2025

Hapvida Participações e Investimentos released its Q3 2025 earnings on November 13, 2025, summarizing the period's financial results.

7 months ago - Filings

Hapvida Participações e Investimentos Slides: Q3 2025

Hapvida Participações e Investimentos has posted slides in relation to its Q3 2025 quarterly earnings report, which was published on November 13, 2025.

7 months ago - Filings

Hapvida Participações e Investimentos Earnings Call Transcript: Q2 2025

Integration completed, with focus shifting to growth, technology, and care quality. Q2 2025 saw 7.3% revenue growth, strong member additions, and improved cost discipline despite one-off provisions. Outlook remains positive with new products, robust pipelines, and continued deleveraging.

11 months ago - Transcripts

Hapvida Participações e Investimentos Earnings release: Q2 2025

Hapvida Participações e Investimentos released its Q2 2025 earnings on August 14, 2025, summarizing the period's financial results.

11 months ago - Filings

Hapvida Participações e Investimentos Slides: Q2 2025

Hapvida Participações e Investimentos has posted slides in relation to its Q2 2025 quarterly earnings report, which was published on August 14, 2025.

11 months ago - Filings